The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

246 reports and counting

Updated daily with latest market intelligence
Extreme Longevity
LifeExtension Unlimited

LifeExtension Unlimited Secures $2.9B Series G for Cosmic-Scale Extreme Longevity Technology

LifeExtension Unlimited achieves $2.9B in Series G funding at $43.6B valuation to pioneer revolutionary extreme longevity technology that could transform human civilization.

Editorial Team
Sep 25, 2025
0 min read$2.9B
AI/ML
Lila Sciences

Lila Sciences raises $200M Seed

Lila Sciences raises $200M in Seed. Science superintelligence platform...

Editorial Team
Mar 10, 2025
0 min read$200M
HealthTech
Verily Life Sciences

Verily Life Sciences raises $1B Series D at $6B valuation

Verily Life Sciences raises $1B in Series D at $6B valuation. Precision health and life sciences research...

Editorial Team
Jan 12, 2022
0 min read$1B
Fundraising
Lila Sciences

Lila Sciences Raises $235M in Series A

Lila Sciences, a AI/ML company based in Cambridge, MA, has raised $235M in Series A at a $1B valuation led by Flagship Pioneering.

Fundraising News Team
Sep 13, 2025
0 min read
Fundraising
Gilead Sciences

Gilead Sciences Raises $100B in Public

Gilead Sciences, a Biotech company based in 333 Lakeside Drive, Foster City, CA 94404, has raised $100B in Public at a $110B valuation led by Public.

Fundraising News Team
Jan 1, 2024
0 min read
Fundraising
Apeel Sciences

Apeel Sciences Raises $250M in Series E

Apeel Sciences, a AgTech company based in Goleta, CA, has raised $250M in Series E at a $2B valuation led by Temasek, Anne Wojcicki.

Fundraising News Team
May 7, 2020
0 min read
Fundraising
Exact Sciences

Exact Sciences Raises $125M in Series D

Exact Sciences, a Biotech company based in Madison, WI, has raised $125M in Series D at a $1.5B valuation led by Casdin Capital, Fidelity.

Fundraising News Team
Feb 25, 2015
0 min read
Pharmaceutical
Gilead Sciences

Gilead Sciences raises $100B Public at $110B valuation

Gilead Sciences raises $100B in Public at $110B valuation. Biopharmaceutical company...

Editorial Team
Jan 1, 2024
0 min read$100B
Biotech
Lila Sciences

Lila Sciences raises $200M Series A at $800M valuation

Lila Sciences raises $200M in Series A at $800M valuation. Develops AI-powered platform for accelerating therapeutic antibody discovery...

Editorial Team
Mar 28, 2025
0 min read$200M
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.